Skip to main content
    N

    Neurogene Inc (NGNE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $23.10
    -0.20 (-0.86%)

    Market Cap: $482.33M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Neurogene Inc (NGNE) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Neurogene (NGNE) has a market cap of $482.33M and an enterprise value of $403.39M. Its share count is up 30.83% from a year earlier. It holds $78.94M more cash than debt, 16.37% of its market cap.

    Total Valuation

    Enterprise value is 16.37% below the market cap, as cash exceeds debt.

    Market Cap$482.33M
    Enterprise Value$403.39M
    Latest price (Nov 17, 2026)$23.10

    Key Dates

    The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 22, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 22.81% in the quarter ended Sep 30, 2026 and grew 27.81% a year over 2 years.

    Shares Outstanding27.70M
    Shares Change (YoY)+30.83%
    Shares Change (QoQ)+22.81%
    Share Count Growth (2Y CAGR)+27.81%

    Price Statistics

    The stock is up 1.45% over 52 weeks and trades 16.33% below its 50-day average.

    Beta (1Y)1.44
    52-Week Change+1.45%
    1-Month Change-4.43%
    3-Month Change-41.42%
    6-Month Change-14.06%
    5-Year Change-81.21%
    10-Year Change-86.84%
    Total Return (1Y)+1.45%
    Total Return (3Y CAGR)+19.90%
    Total Return (5Y CAGR)-26.75%
    Return vs SPY (1Y)-3.41%
    Max Drawdown (1Y)-49.67%
    Max Drawdown (3Y)-89.74%
    Sharpe Ratio (1Y)0.11
    Correlation with SPY (1Y)0.27
    50-Day Average$27.61
    200-Day Average$28.22
    52-Week Range$15.93 to $43.66
    RSI (14 Days)38.5
    Average Volume (20 Days)297.67K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 19.97x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio19.97x
    Quick Ratio19.97x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on invested capital is -28.54% over the last 12 months, against a 5-year average of -30.39%.

    Return on Equity (ROE)-33.59%
    Return on Assets (ROA)-31.54%
    Return on Invested Capital (ROIC)-28.54%
    ROA (5Y Average)-31.54%
    ROIC (5Y Average)-30.39%

    Scores

    NGNE has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$787.00K
    Operating Income-$129.93M
    Pretax Income-$117.96M
    Net Income-$119.18M
    Reported EPS (TTM)-$5.10

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 93.88% of the $377.90M in total assets.

    Cash and Equivalents$78.94M
    Total Debt$2.00K
    Net Cash$78.94M
    Net Cash Per Share$2.85
    Working Capital$344.58M
    Shareholder Equity$354.79M
    Book Value Per Share$12.81
    Total Assets$377.90M
    Total Liabilities$23.11M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.08M of capital spending, operating cash flow left -$97.53M of free cash flow.

    Operating Cash Flow-$96.45M
    Capital Expenditures$1.08M
    Free Cash Flow-$97.53M
    FCF Per Share-$4.87
    Depreciation and Amortization$6.64M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)+8.57%
    Tangible Book Per Share Growth (2Y CAGR)+8.57%

    Revenue and profit by year

    Dividends and Yields

    NGNE does not pay a dividend. Its free cash flow yield is -15.24%.

    FCF Yield-15.24%
    Buyback Yield-2.29%
    Shareholder Yield-2.29%

    Stock Splits

    The last split was a 1-for-4 reverse split on Dec 19, 2023.

    Last Split DateDec 19, 2023
    Split TypeReverse split
    Split Ratio1:4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About NGNE

    What is NGNE's market cap?

    Neurogene has a market cap of $482.33M. Its enterprise value, which adds debt and subtracts cash, is $403.39M.

    How many shares of NGNE are outstanding?

    Neurogene has 27.70M shares outstanding. The count is up 30.83% from a year earlier.

    Does NGNE pay a dividend?

    No. Neurogene does not pay a dividend.

    How much debt does NGNE have?

    Neurogene has $2.00K of total debt and $78.94M of cash and equivalents, a net cash position of $78.94M.